nderstanding the effects of add-on yoga therapy on immuno-inflammatory markers in schizophrenia

Wellcome Trust DBT India Alliance0 个研究点目标入组 90 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•For Patients:
•1. Diagnosis of schizophrenia (DSM V).
•2. Clinical Global Impression â?? Severity (CGI-S)Score equal to or more than 3.
•3. Stable medication for 6 weeks.
•4. Right-handedness.
•5. Written informed consent.
•For Healthy Controls:
•1. Right-handedness.
•2. Written informed consent.

•For Patients:
•1. Risk of harm to self or others.
•2. Need for Electroconvulsive therapy.
•3. Subjects who are already practicing/ recent practice of yoga/ meditation.
•4. Recent history of high-grade fever/infection within the past 6 weeks.
•5. Co-existing disease that can potentially influence immune system.
•6. Treatment with medications known to affect immune system.
•7. Significant neurological disorder including seizure disorder or recent head injury.
•8. Family history of neurological disorder that may complicate diagnosis (for example Huntingtonâ??s chorea)
•9. Co-morbid substance dependence in the past 6 months or substance abuse in the past 1month as per DSM - V, except nicotine.
•10. Pregnancy or postpartum ( <6 weeks after delivery)
•For Healthy Controls:
•1. Diagnosis of a psychiatric disorder.
•2. Family history of psychiatric disorder in any of the first-degree relatives
•3. Recent history of high-grade fever/infection within the past 6 weeks
•4. Co-existing disease including autoimmune/inflammatory conditions that can
•potentially influence immune system
•5. Treatment with medications known to affect immune systems
•6. Pregnancy or postpartum
•7. Co-morbid substance dependence in the past 6 months or substance abuse in the past 1month as per DSM - V, except nicotine.

发起方

Wellcome Trust DBT India Alliance